NCT05241132 2022-02-15
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Shanghai Changzheng Hospital
Phase 2 Unknown
Shanghai Changzheng Hospital
Zhujiang Hospital
Shenzhen Hornetcorn Bio-technology Company, LTD
Seoul National University Bundang Hospital
The University of Texas Health Science Center, Houston